Sugardown® presently is a food supplement for regulation of after-meal post-prandial blood sugar increase. Sugardown® formulation is made up of ingredients certified in 2010 by US-FDA as Generally Recognized as Safe (GRAS). Sugardown® has been test marketed in North America, Asia (Hong Kong & Macau, Korea, Singapore, Myanmar and Brunei) and is being explored in Japan, and China in 2018.

Made up of patented galactomannan formulation and indicated as the first line defense against dietary sugar uptake, Sugardown® has gone through clinical trials in US, Australia and Asia with efficacy endpoints in management of after-meal sugar levels.

Sugardown® is non-systemic and works predominately to reduce the glycemic impact of carbohydrate foods and sugary drinks before they are absorbed as glucose. Sugardown®'s single molecule structure has no limited side-effects and no known drug interaction. Sugardown® inhibits sugar metabolism in the digestive tracts and has shown to prevent up to 60% of absorption of dietary sugars after the meal.

Sugardown® may induce a feeling of fullness (satiety) and hence support meal portion control. Sugardown® can serve as a part of diabetes/weight management plan. At present, Sugardown® is 100% made in the USA in FDA-inspected facilities with the highest level of integrity and oversight, in accordance with Good Manufacturing Practices (GMP) for this material.

Sugardown® Clinical Studies

SugarDown CSR_SG01_Final 19-Jun-2017.pdf

Sugardown Soft Drink Report_Final_Fully executed_15122015.pdf

SugarDown_Study_Report_SUGIRS_v2_0811_SDHK executed.pdf